EU committee backs approval of Roche’s Actemra/RoActemra to treat Covid-19
Roche said that the data from four clinical studies showed that Actemra/RoActemra reduced the risk of death in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Dec 21
Roche said that the data from four clinical studies showed that Actemra/RoActemra reduced the risk of death in…
06 Dec 21
The provisional approval allows children aged five to 11 years to receive the vaccine in two doses, at…
03 Dec 21
Sotrovimab showed activity against mutations of the new Omicron variant (B.1.1.529), according to preclinical data published in bioRxiv
02 Dec 21
Kyprolis in combination with Darzalex Faspro and dexamethasone expands the options for the treatment of relapsed/refractory multiple myeloma
30 Nov 21
The EC approvals for Keytruda plus Lenvima are based on results from CLEAR/KEYNOTE-581 trial and Phase 3 KEYNOTE-775/Study…
26 Nov 21
If approved, Comirnaty becomes the first Covid-19 vaccine authorised in the EU in the five to 11 years…
25 Nov 21
J&J’s single-shot vaccine showed 85% protection against Covid-19 related hospitalisation and death, and across different variants
24 Nov 21
Livtencity is an orally bioavailable anti-CMV compound that works by blocking the activity of the human cytomegalovirus enzyme…
24 Nov 21
The EC marketing authorisation was based on results from the Phase 3 ASCENT study of Trodelvy in people…
22 Nov 21
Gavreto is a once-daily, oral precision medicine that works by selectively targeting rearranged during transfection (RET) alterations, including…